Select Language

Envelope protein

Envelope protein Overview

English Name	Recombinant envelope protein	Approved Drugs	1
Drugs in Clinical Trials	6	Target Synonym	env，Submitted name: Recombinant envelope protein，Viral Envelope Proteins
Highest Development Stage	Approved

English Name	Recombinant envelope protein
Target Synonym	env，Submitted name: Recombinant envelope protein，Viral Envelope Proteins
Approved Drugs	1
Drugs in Clinical Trials	6
Highest Development Stage	Approved

Envelope protein Product List

Product Category
Protein (2)Kits (1)
Product Status
Launched (3)
Species
SARS-CoV-2 (1)pHERV-W (1)- (1)
Tag
His Tag & GST Tag (1)His Tag (1)- (1)
Conjugate
Unconjugated (2)- (1)

Cat. No.	Species	Host	Product Description
ENN-C5128	SARS-CoV-2	E. coli	SARS-CoV-2 (COVID-19) Envelope protein, GST,His Tag
ENN-V5243	pHERV-W	HEK293	pHERV-W Envelope protein, His Tag
RAS-A236	-	-	Japanese encephalitis Virus Envelope protein (E) Specific ELISA Kit

Total: 3

Envelope protein Background

The SARS-CoV-2 is composed of a double-layered lipid envelope, including Spike glycoprotein (S), Envelope protein (E), Membrane glycoprotein (M), and Nucleocapsid protein (Nucleocapsid protein, N). Among them, The amino acid sequence of the SARS-CoV-2 envelope protein is 95% identical of the SARS envelope protein.

Envelope protein Synonyms

Envelope protein,Env polyprotein,Envelope glycoprotein,env

Clinical Drug Information

English Name	Research Code	Highest Development Stage	Company	Indication	Clinical Trial
Targeting HIV-1 Env gp140 antibodies		Phase 2 Clinical	National Institute Of Allergy And Infectious Diseases (Niaid)	HIV Infections	Details
Temelimab	GNN-001; GENHP-01; GNbAC-1	Phase 2 Clinical	Geneuro Sa	Diabetes Mellitus, Type 1; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Post-Acute COVID-19 Syndrome	Details
VIS-513	VIS-513; Ab-513	Phase 2 Clinical	Otsuka Pharmaceutical Co Ltd, Serum Institute Of India Ltd, Visterra Inc	Dengue	Details
PGDM-1400	PGDM-1400; PGDM1400LS	Phase 2 Clinical	International Aids Vaccine Initiative	Acquired Immunodeficiency Syndrome; HIV Infections; Sexually Transmitted Diseases, Viral	Details
MGD-020	MGD020	Phase 1 Clinical	Macrogenics Inc	HIV Infections	Details
GS-8588	GS-8588	Phase 1 Clinical	Gilead Sciences Inc	HIV Infections	Details

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	Earliest Brand Name	Earliest Approval Country	Earliest Indication	Earliest Approval Company	Earliest Approval Date	Indication	Clinical Trial
Tecovirimat	SIGA-246; ST-246	Approved	Siga Technologies Inc	Tpoxx, Arestvyr	United States	Smallpox	Siga Technologies Inc	2018-07-13	Cowpox; Monkeypox; Orthopoxvirus Infection; Poxviridae Infections; Smallpox; Vaccinia	Details